Endurance Wealth Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $37K | Hold |
500
| – | – | 0.01% | 370 |
|
|
2023
Q1 | $27K | Buy |
500
+250
| +100% | +$13.5K | ﹤0.01% | 409 |
|
|
2022
Q4 | $17K | Hold |
250
| – | – | ﹤0.01% | 424 |
|
|
2022
Q3 | $31K | Hold |
250
| – | – | 0.01% | 371 |
|
|
2022
Q2 | $24K | Hold |
250
| – | – | ﹤0.01% | 395 |
|
|
2022
Q1 | $40K | Buy |
250
+125
| +100% | +$20K | 0.01% | 376 |
|
|
2021
Q4 | $42K | Buy |
125
+75
| +150% | +$25.2K | ﹤0.01% | 369 |
|
|
2021
Q3 | $23K | Buy |
+50
| New | +$23K | ﹤0.01% | 434 |
|